What are the realistic expectations of tocolytics?

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue SUPPL. 20, 2003, Pages 103-106

  Smith, Graeme N ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CORTICOSTEROID; INDOMETACIN; MAGNESIUM SULFATE; RITODRINE; UTERUS SPASMOLYTIC AGENT;

AMNION FLUID; BIOAVAILABILITY; BRAIN HEMORRHAGE; CANADA; CEREBRAL PALSY; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DISABILITY; HEALTH CARE COST; HEART PALPITATION; HUMAN; MEDICAL RESEARCH; NECROTIZING ENTEROCOLITIS; NEWBORN MORBIDITY; NEWBORN MORTALITY; PERINATAL CARE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; REDUCTION; RISK FACTOR; SIDE EFFECT; TACHYCARDIA; TOCOLYSIS;

EID: 0038664209     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(03)00053-3     Document Type: Conference Paper

References (18)

1. Moutquin J-M Preterm births in Canada. Where do we go from here? JSOGC. 21:1999;12-15.
2. Hannah M.E. Search for best tocolytic for preterm labour. Lancet. 356:2000;699-700.
3. Tyson J.E. Use of unproven therapies in clinical practice and research: how can we better serve our patients and their families? Sem Perinatol. 19:1995;98-111.
4. Joseph K.S., Kramer M.S., Marcoux Set al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med. 339:1998;1434-1439.
5. Liu G, Hannah ME. Canadian Tocolytic Survey, 1999 (Personal communication).
6. Pryde P.G., Besinger R.E., Gianopoulos J.G., Mittendorf R. Adverse and beneficial effects of tocolytic therapy. Sem Perinatol. 25:2001;316-340.
7. Gyetvai K., Hannah M.E., Hodnett E.D., Ohlsson A. Tocolytics for preterm labor: a systematic review. Obstet Gynecol. 94:1999;869-877.
8. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med. 327:1992;308-312.
9. Panter K.R., Hannah M.E., Amankwah K.S., Ohlsson A., Jefferies A.L., Farine D. The effect of indomethacin tocolysis for preterm labour on perinatal outcome: a randomized placebo controlled trial. Br J Obstet Gynaecol. 106:1999;467-473.
10. Robertson P.A., Sniderman S.H., Laros RKet al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol. 166:1992;1629-1645.
11. Challis J.R.G., Lye S.J., Gibb W., Whittle W., Patel F., Alfaidy N. Understanding preterm labour. Ann N Y Acad Sci. 943:2001;225-234.
12. Crowley P. Prophylactic corticosteroids for preterm delivery. [Cochrane review] The Cochrane Library. 2002;Update Software, Oxford.
13. Guinn D.A., Atkinson M.W., Sullivan Let al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery. JAMA. 286:2001;1581-1587.
14. Smith G.N., Kingdom J.C.P., Penning D.H., Matthews S.G. Antenatal corticosteroids: is more better? Lancet. 355:2000;251-252.
15. Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol. 98:2001;144-150.
16. Yoon B.H., Kim C.J., Romero Ret al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 177:1997;797-802.
17. Gaudet L., Smith G.N. Cerebral palsy and chorioamnionitis: the inflammatory cytokine link. Obstet Gynecol Surv. 56:2001;433-436.
18. Gibbs R.S., Romero R., Hillier S.L., Eschenbach D.A., Sweet R.L. A review of premature birth and subclinical infection. Am J Obstet Gynecol. 166:1992;1515-1528.